Patents Assigned to Qingdao Primedicine Pharmaceutical Company, Ltd.
  • N-methyl-d-aspartate receptor allosteric modulators and methods for their use
    Patent number: 11166924
    Abstract: This invention relates to therapeutic compounds and compositions, and methods for their use in the prevention or treatment of neurological disorders. In particular, the invention relates to N-methyl-D-aspartate receptor (NMDAR) allosteric modulators and methods for their use in the prevention or treatment of disorders or conditions caused by or related to NMDAR dysfunctions. The invention also relates to a method for identifying NMDAR allosteric modulators.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: November 9, 2021
    Assignee: Qingdao Primedicine Pharmaceutical Company, Ltd.
    Inventors: Yu Tian Wang, Peter Axerio-Cilies
  • N-METHYL-D-ASPARTATE RECEPTOR ALLOSTERIC MODULATORS AND METHODS FOR THEIR USE
    Publication number: 20190216753
    Abstract: This invention relates to therapeutic compounds and compositions, and methods for their use in the prevention or treatment of neurological disorders. In particular, the invention relates to N-methyl-D-aspartate receptor (NMDAR) allosteric modulators and methods for their use in the prevention or treatment of disorders or conditions caused by or related to NMDAR dysfunctions. The invention also relates to a method for identifying NMDAR allosteric modulators.
    Type: Application
    Filed: September 26, 2017
    Publication date: July 18, 2019
    Applicant: Qingdao Primedicine Pharmaceutical Company, Ltd.
    Inventors: Yu Tian Wang, Peter Axerio-Cilies